Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system
Journal of Clinical Virology(2021)
摘要
•Differential diagnosis of COVID-19 and FLU is vital for proper disease management.•Molecular-based diagnostics have high sensitivity for the detection of virus.•MAX SARS-CoV-2/flu assays met FDA-EUA criteria for SARS-CoV-2 detection.•MAX SARS-CoV-2/flu assays met FDA clearance criteria for FLU A/B detection.
更多查看译文
关键词
BD MAX,COVID-19,SARS-CoV-2,Influenza,Multiplex RT-PCR assay
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要